Global Varicella Vaccine Effectiveness: A Meta-analysis
Mona Marin1, Melanie Marti2, Anita Kambhampati3
1National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and mmarin@cdc.gov.
One dose of varicella vaccine offers moderate protection against all chickenpox and high protection against severe cases. A second dose further improves protection against all varicella disease.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Varicella vaccines are globally available, with national programs typically employing 1- or 2-dose schedules.
- Understanding vaccine effectiveness is crucial for public health policy and disease prevention strategies.
Purpose of the Study:
- To evaluate postlicensure estimates of varicella vaccine effectiveness (VE) in healthy children.
- To synthesize existing data on the efficacy of varicella vaccination schedules.
Main Methods:
- A systematic review and meta-analysis of studies published between 1995 and 2014.
- Inclusion criteria focused on original data of dose-specific varicella VE in immunocompetent children.
- Random effects models were used to pool estimates by disease severity and dose number.
Main Results:
- One dose of varicella vaccine showed 81% effectiveness against all varicella and 98% against moderate/severe cases.
- Effectiveness did not significantly vary by vaccine type or study design for a single dose.
- The pooled two-dose VE against all varicella was 92%.
Conclusions:
- One dose of varicella vaccine is moderately effective against all varicella and highly effective against moderate to severe varicella.
- A second dose of the vaccine provides enhanced protection against all forms of varicella.
- Findings support the use of both one and two-dose varicella vaccination schedules.
More Related Videos
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
Related Concept Videos
Vaccinations
Vaccines
Antimicrobial Effectiveness
